Cargando…
Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition
Systemic juvenile idiopathic arthritis (SJIA) is a disease marked with arthritis and several features of systemic inflammation including fevers, rashes, hepatosplenomegaly, lymphadenopathy, and serositis. The presentation can be variable and arthritis can be a later feature. Macrophage activation sy...
Autores principales: | Grevich, Sriharsha, Shenoi, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687245/ https://www.ncbi.nlm.nih.gov/pubmed/29184458 http://dx.doi.org/10.2147/AHMT.S109495 |
Ejemplares similares
-
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
por: Giancane, Gabriella, et al.
Publicado: (2016) -
The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
por: Toplak, Nataša, et al.
Publicado: (2018) -
IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
por: Yokota, S, et al.
Publicado: (2003) -
Review of environmental factors and juvenile idiopathic arthritis
por: Horton, Daniel B, et al.
Publicado: (2019) -
DNA methylation at IL32 in juvenile idiopathic arthritis
por: Meyer, Braydon, et al.
Publicado: (2015)